Cargando…

Estrogen receptor degradation: a CUE for endocrine resistance?

Despite the undoubted success of adjuvant endocrine therapies that target the estrogen receptor pathway, not all women with estrogen receptor-positive breast cancer respond to these therapies, and many who initially respond will subsequently relapse. Deregulation of various aspects of estrogen recep...

Descripción completa

Detalles Bibliográficos
Autor principal:	Musgrove, Elizabeth A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236333/ https://www.ncbi.nlm.nih.gov/pubmed/21861853 http://dx.doi.org/10.1186/bcr2914

Ejemplares similares

Live or let die: oestrogen regulation of survival signalling in endocrine response
por: Butt, Alison J, et al.
Publicado: (2007)

More on FOX News: FOXA1 on the horizon of estrogen receptor function and endocrine response
por: Fu, Xiaoyong, et al.
Publicado: (2011)

Amping up estrogen receptors in breast cancer
por: Fowler, Amy M, et al.
Publicado: (2007)

Cannibalism, cell survival, and endocrine resistance in breast cancer
por: Clarke, Robert
Publicado: (2011)

Estrogen receptor action in three dimensions - looping the loop
por: Theodorou, Vasiliki, et al.
Publicado: (2010)

Estrogen-related receptor alpha: an orphan finds a family
por: Ochnik, Aleksandra M, et al.
Publicado: (2012)

Estrogen-repressed genes – key mediators of estrogen action?
por: Zubairy, Simeen, et al.
Publicado: (2005)

What does an orphan G-protein-coupled receptor have to do with estrogen?
por: Rae, James M, et al.
Publicado: (2005)

To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression
por: Watters, Rebecca J, et al.
Publicado: (2012)

Endocrine therapy: defining the path of least resistance
por: Stone, Andrew, et al.
Publicado: (2014)

The molecular classification of hereditary endocrine diseases
por: Ye, Lei, et al.
Publicado: (2015)

Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
por: Wang, Yubo, et al.
Publicado: (2023)

Understanding endocrine resistance: the critical need for sequential samples from clinical breast cancer and novel in vitro models
por: Gee, Julia MW, et al.
Publicado: (2005)

Bringing the Pediatric Endocrine Spanish Speaking Community Together: First Virtual Pediatric Endocrine Meeting in Low- and Middle-Income Countries in Central and South America
por: Bogarin, Roberto, et al.
Publicado: (2023)

Endocrine system dysfunction and chronic heart failure: a clinical perspective
por: Lisco, Giuseppe, et al.
Publicado: (2021)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability
por: Jeffreys, Sarah A., et al.
Publicado: (2020)

Editorial: Estrogen receptors in endocrine disorders
por: Filardi, Tiziana, et al.
Publicado: (2023)

Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage
por: LaMarca, Heather L, et al.
Publicado: (2007)

Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

Bringing Virtual Reality From Clinical Trials to Clinical Practice for the Treatment of Eating Disorders: An Example Using Virtual Reality Cue Exposure Therapy
por: Brown, Theresa, et al.
Publicado: (2020)

Non-canonical Estrogen Signaling in Endocrine Resistance
por: Ranganathan, Prathibha, et al.
Publicado: (2019)

Integrin-mediated resistance to epidermal growth factor receptor-targeted therapy: an inflammatory situation
por: Brown, Wells S, et al.
Publicado: (2014)

Corrigendum: Molecular Mechanisms of Endocrine Resistance in Estrogen-Receptor-Positive Breast Cancer
por: Belachew, Esmael Besufikad, et al.
Publicado: (2021)

Centriolar satellites prevent uncontrolled degradation of centrosome proteins: a speculative review
por: Lecland, Nicolas, et al.
Publicado: (2018)

Biomarker Genes for Detecting Estrogenic Activity of Endocrine Disruptors via Estrogen Receptors
por: Jung, Eui-Man, et al.
Publicado: (2012)

AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer - culprits for resistance to EGFR inhibitors?
por: Heideman, Marinus R, et al.
Publicado: (2013)

Estrogen Receptors as Molecular Targets of Endocrine Therapy for Glioblastoma
por: González-Mora, Andrea Magali, et al.
Publicado: (2021)

Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
por: Liu, Shuying, et al.
Publicado: (2014)

Elacestrant demonstrates strong anti-estrogenic activity in PDX models of estrogen-receptor positive endocrine-resistant and fulvestrant-resistant breast cancer
por: Pancholi, Sunil, et al.
Publicado: (2022)

Practical Guidelines for Diagnosing and Treating Thyroid Disease Based on the WOMED Metabolic Model of Disease Focusing on Glycolysis and Coenzyme Q(10) Deficiency—A Clinical Alternative to the 2021 Retired Clinical Practice Guidelines of the Endocrine Society
por: Moncayo, Roy, et al.
Publicado: (2022)

SAT-341 Pharmacology and Metabolism of GLL398 an Oral Selective Estrogen Receptor Degrader for Endocrine Therapy of Breast Cancer
por: Guo, Shanchun, et al.
Publicado: (2019)

Toxicological Mechanism of Endocrine Disrupting Chemicals:Is Estrogen Receptor Involved?
por: Jeung, Eui-Bae, et al.
Publicado: (2010)

Estrogen-Inducible LncRNA BNAT1 Functions as a Modulator for Estrogen Receptor Signaling in Endocrine-Resistant Breast Cancer Cells
por: Horie, Kuniko, et al.
Publicado: (2022)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer
por: Castillo-Castrejon, Marisol, et al.
Publicado: (2023)

Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
por: Mao, XiaoDan, et al.
Publicado: (2019)

Pathways for nicotinic receptor desensitization
por: Auerbach, Anthony
Publicado: (2020)

Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer
por: Xia, Youli, et al.
Publicado: (2022)

A call to action—stopping antimicrobial resistance
por: Eisinger, Robert W, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4cl456chco0fh3hdsn2nr0en0c